The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Pharmaceuticals Market Research Report 2024
Synopsis
Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
The global Pet Pharmaceuticals market was valued at US$ 14270 million in 2023 and is anticipated to reach US$ 23040 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
This report aims to provide a comprehensive presentation of the global market for Pet Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Pharmaceuticals.
Report Scope
The Pet Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Segment by Application
Prevention
Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
The global Pet Pharmaceuticals market was valued at US$ 14270 million in 2023 and is anticipated to reach US$ 23040 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
This report aims to provide a comprehensive presentation of the global market for Pet Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Pharmaceuticals.
Report Scope
The Pet Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Segment by Type
Antiparasitic
Biological Products
Antibacterial
Others
Segment by Application
Prevention
Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pet Pharmaceuticals Market Overview
1.1 Product Overview and Scope of Pet Pharmaceuticals
1.2 Pet Pharmaceuticals Segment by Type
1.2.1 Global Pet Pharmaceuticals Market Value Comparison by Type (2024-2030)
1.2.2 Antiparasitic
1.2.3 Biological Products
1.2.4 Antibacterial
1.2.5 Others
1.3 Pet Pharmaceuticals Segment by Application
1.3.1 Global Pet Pharmaceuticals Market Value by Application: (2024-2030)
1.3.2 Prevention
1.3.3 Treatment
1.4 Global Pet Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Pet Pharmaceuticals Revenue 2019-2030
1.4.2 Global Pet Pharmaceuticals Sales 2019-2030
1.4.3 Global Pet Pharmaceuticals Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Pharmaceuticals Market Competition by Manufacturers
2.1 Global Pet Pharmaceuticals Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Pharmaceuticals Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Pharmaceuticals Average Price by Manufacturers (2019-2024)
2.4 Global Pet Pharmaceuticals Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Pharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Pharmaceuticals, Product Type & Application
2.7 Pet Pharmaceuticals Market Competitive Situation and Trends
2.7.1 Pet Pharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Pharmaceuticals Players Market Share by Revenue
2.7.3 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Pharmaceuticals Retrospective Market Scenario by Region
3.1 Global Pet Pharmaceuticals Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Pharmaceuticals Global Pet Pharmaceuticals Sales by Region: 2019-2030
3.2.1 Global Pet Pharmaceuticals Sales by Region: 2019-2024
3.2.2 Global Pet Pharmaceuticals Sales by Region: 2025-2030
3.3 Global Pet Pharmaceuticals Global Pet Pharmaceuticals Revenue by Region: 2019-2030
3.3.1 Global Pet Pharmaceuticals Revenue by Region: 2019-2024
3.3.2 Global Pet Pharmaceuticals Revenue by Region: 2025-2030
3.4 North America Pet Pharmaceuticals Market Facts & Figures by Country
3.4.1 North America Pet Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Pharmaceuticals Sales by Country (2019-2030)
3.4.3 North America Pet Pharmaceuticals Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Pharmaceuticals Market Facts & Figures by Country
3.5.1 Europe Pet Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Pharmaceuticals Sales by Country (2019-2030)
3.5.3 Europe Pet Pharmaceuticals Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Pharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Pharmaceuticals Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Pharmaceuticals Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pet Pharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America Pet Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Pharmaceuticals Sales by Country (2019-2030)
3.7.3 Latin America Pet Pharmaceuticals Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Pharmaceuticals Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Pharmaceuticals Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Pharmaceuticals Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Pharmaceuticals Sales by Type (2019-2030)
4.1.1 Global Pet Pharmaceuticals Sales by Type (2019-2024)
4.1.2 Global Pet Pharmaceuticals Sales by Type (2025-2030)
4.1.3 Global Pet Pharmaceuticals Sales Market Share by Type (2019-2030)
4.2 Global Pet Pharmaceuticals Revenue by Type (2019-2030)
4.2.1 Global Pet Pharmaceuticals Revenue by Type (2019-2024)
4.2.2 Global Pet Pharmaceuticals Revenue by Type (2025-2030)
4.2.3 Global Pet Pharmaceuticals Revenue Market Share by Type (2019-2030)
4.3 Global Pet Pharmaceuticals Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Pharmaceuticals Sales by Application (2019-2030)
5.1.1 Global Pet Pharmaceuticals Sales by Application (2019-2024)
5.1.2 Global Pet Pharmaceuticals Sales by Application (2025-2030)
5.1.3 Global Pet Pharmaceuticals Sales Market Share by Application (2019-2030)
5.2 Global Pet Pharmaceuticals Revenue by Application (2019-2030)
5.2.1 Global Pet Pharmaceuticals Revenue by Application (2019-2024)
5.2.2 Global Pet Pharmaceuticals Revenue by Application (2025-2030)
5.2.3 Global Pet Pharmaceuticals Revenue Market Share by Application (2019-2030)
5.3 Global Pet Pharmaceuticals Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Pet Pharmaceuticals Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Pet Pharmaceuticals Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Pet Pharmaceuticals Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description and Business Overview
6.5.3 Virbac Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Virbac Pet Pharmaceuticals Product Portfolio
6.5.5 Virbac Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Corporation Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Pet Pharmaceuticals Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetoquinol Pet Pharmaceuticals Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Ouro Fino Saude
6.9.1 Ouro Fino Saude Corporation Information
6.9.2 Ouro Fino Saude Description and Business Overview
6.9.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ouro Fino Saude Pet Pharmaceuticals Product Portfolio
6.9.5 Ouro Fino Saude Recent Developments/Updates
6.10 Norbrook
6.10.1 Norbrook Corporation Information
6.10.2 Norbrook Description and Business Overview
6.10.3 Norbrook Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Norbrook Pet Pharmaceuticals Product Portfolio
6.10.5 Norbrook Recent Developments/Updates
6.11 Jindun
6.11.1 Jindun Corporation Information
6.11.2 Jindun Pet Pharmaceuticals Description and Business Overview
6.11.3 Jindun Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jindun Pet Pharmaceuticals Product Portfolio
6.11.5 Jindun Recent Developments/Updates
6.12 Chopperlvya Animal Health
6.12.1 Chopperlvya Animal Health Corporation Information
6.12.2 Chopperlvya Animal Health Pet Pharmaceuticals Description and Business Overview
6.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio
6.12.5 Chopperlvya Animal Health Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Corporation Information
6.13.2 CAHIC Pet Pharmaceuticals Description and Business Overview
6.13.3 CAHIC Pet Pharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CAHIC Pet Pharmaceuticals Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Pharmaceuticals Industry Chain Analysis
7.2 Pet Pharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Pharmaceuticals Production Mode & Process
7.4 Pet Pharmaceuticals Sales and Marketing
7.4.1 Pet Pharmaceuticals Sales Channels
7.4.2 Pet Pharmaceuticals Distributors
7.5 Pet Pharmaceuticals Customers
8 Pet Pharmaceuticals Market Dynamics
8.1 Pet Pharmaceuticals Industry Trends
8.2 Pet Pharmaceuticals Market Drivers
8.3 Pet Pharmaceuticals Market Challenges
8.4 Pet Pharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
